A detailed history of Intech Investment Management LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Intech Investment Management LLC holds 102,595 shares of NBIX stock, worth $12.6 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
102,595
Previous 68,698 49.34%
Holding current value
$12.6 Million
Previous $9.46 Million 24.89%
% of portfolio
0.14%
Previous 0.12%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$114.58 - $153.15 $3.88 Million - $5.19 Million
33,897 Added 49.34%
102,595 $11.8 Million
Q2 2024

Aug 12, 2024

BUY
$130.86 - $143.19 $5.82 Million - $6.37 Million
44,512 Added 184.04%
68,698 $9.46 Million
Q1 2024

May 10, 2024

BUY
$130.4 - $143.74 $1.55 Million - $1.71 Million
11,921 Added 97.2%
24,186 $3.34 Million
Q4 2023

Oct 18, 2024

SELL
$106.07 - $132.76 $565,140 - $707,345
-5,328 Reduced 30.28%
12,265 $1.62 Million
Q4 2023

Feb 09, 2024

SELL
$106.07 - $132.76 $565,140 - $707,345
-5,328 Reduced 30.28%
12,265 $1.62 Million
Q3 2023

Oct 18, 2024

SELL
$94.02 - $117.1 $290,333 - $361,604
-3,088 Reduced 14.93%
17,593 $1.98 Million
Q3 2023

Nov 13, 2023

SELL
$94.02 - $117.1 $402,593 - $501,422
-4,282 Reduced 19.57%
17,593 $1.98 Million
Q2 2023

Oct 18, 2024

BUY
$89.53 - $104.87 $1.47 Million - $1.72 Million
16,398 Added 382.86%
20,681 $1.95 Million
Q2 2023

Aug 09, 2023

BUY
$89.53 - $104.87 $1.47 Million - $1.72 Million
16,398 Added 299.4%
21,875 $2.06 Million
Q1 2023

Oct 18, 2024

SELL
$94.11 - $123.02 $6.06 Million - $7.92 Million
-64,415 Reduced 93.77%
4,283 $433,000
Q1 2023

May 10, 2023

SELL
$94.11 - $123.02 $28,515 - $37,275
-303 Reduced 5.24%
5,477 $554,000
Q4 2022

Oct 18, 2024

BUY
$106.72 - $127.06 $32,336 - $38,499
303 Added 7.07%
4,586 $547,000
Q4 2022

Feb 09, 2023

BUY
$106.72 - $127.06 $159,759 - $190,208
1,497 Added 34.95%
5,780 $690,000
Q3 2022

Oct 18, 2024

SELL
$92.03 - $107.81 $5.93 Million - $6.94 Million
-64,415 Reduced 93.77%
4,283 $454,000
Q3 2022

Nov 10, 2022

BUY
$92.03 - $107.81 $28,253 - $33,097
307 Added 7.72%
4,283 $455,000
Q2 2022

Aug 10, 2022

BUY
$75.79 - $100.07 $301,341 - $397,878
3,976 New
3,976 $388,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.8B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.